MedCity News September 27, 2021
Medical technology companies saw 288 deals between June 2020 and June 2021, the highest amount ever since Ernst & Young began tracking it in 2007. VC funding in medtech also reached a high point of $9.1 billion.
After a brief slowdown last year, dealmaking among medical device companies soared to new heights, according to a new report by Ernst & Young LLP.
Medtech companies saw venture capital investment soar to the highest levels in a decade, and executed the most M&A deals since EY began tracking in 2007.
Between June 2020 and June 2021, medtech companies raised a total of $9.1 billion, up 34% from the previous year. They also closed a total of 288 deals during that time...
Today's Sponsors
Today's Sponsor